Bainbridge Health Is Harnessing Medication Utilization Data to Conserve Waste and Manage The Supply of Critical Care Drugs Used to Treat COVID-19 Patients
Summary
Since the beginning of the pandemic, Bainbridge Health has been closely monitoring network data to identify trends in the utilization of neuromuscular blockers, vasoactive agents, and sedatives. The goal of the webinar was to show usage patterns of these critical care medications at the peak of the pandemic to help inform future supply needs. Given that several of the drugs have gone on shortage, Dr. O’Neill also suggested optimal formulations of these critical care medications based on network data that supports the ability to conserve the most waste. It provides an understanding of how much drug is actually being administered to patients, which can inform decisions about how much medication to purchase and which formulations to make them in,” said Sean O’Neill, PharmD. “Having access to this data in a digestible way is vital to making operational decisions, especially in times of uncertainty like this.” Today, as the number of cases continues to climb and health systems prepare for a resurgence, Bainbridge Health remains committed to sharing trends from its network to help hospitals effectively prepare inventory.